CiMaas and PharmaCell Enter a Collaborative Agreement
News Jul 14, 2015
CiMaas BV and PharmaCell BV have agreed to collaborate in the clinical development of CiMaas’ products. Under the agreement, PharmaCell will provide consulting services on writing GMP-compliant documents for the purpose of translating the CiMaas cell therapy processes into GMP.
Options have been taken on a full technology transfer trajectory to be started and executed at a later date. A continuation option on a Phase I and possibly a Phase II clinical trial is also part of the agreement.
Gerard Bos, Chief Executive Officer of CiMaas said: “We are delighted to collaborate with PharmaCell and receive support in building our documents and technology in a fully GMP compliant manner for the development of our ATMPs (Advanced Therapy Medicinal Products).”
Wilfred Germeraad, Chief Scientific Officer added: “It is a wonderful opportunity to work together and it will immediately speed-up our work in translating the lab procedures into clinical products ready to be tested in patients with cancer.”
Alexander Vos, Chief Executive Officer of PharmaCell BV, said: “The CiMaas team has shown to be successful in bringing their technology to the point of preparing the initiation of clinical studies. We are excited to support them to make their production process GMP-compliant and help clear the path to bring their innovative therapies to benefit patients”.
Drug Discovery Alliance Formed to Help Increase Drug Development Success RateNews
Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.READ MORE
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE
Lonza Introduces the New CytoSMART™ 2 System for Live Cell ImagingNews
Lonza's updated CytoSMART System has an advanced optical system to enable researchers to capture high-resolution images of their cell cultures.READ MORE
Comments | 0 ADD COMMENT
9th International conference on Tissue Engineering and Regenerative Medicine
Nov 09 - Nov 10, 2018